Marea Therapeutics
Clinical trials sponsored by Marea Therapeutics, explained in plain language.
-
New drug aims to tame Post-Meal fat spikes in High-Risk patients
Disease control Recruiting nowThis study tests whether the experimental drug MAR001 can reduce blood fat (triglycerides) after a meal better than a placebo. About 30 adults with high triglycerides will receive either MAR001 or a placebo and have their fat levels measured after eating a mixed meal. The goal is…
Phase: PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:19 UTC
-
New drug MAR002 takes first step in human trials
Knowledge-focused Recruiting nowThis early-stage study tests whether MAR002 is safe and tolerable in healthy men. The drug is being developed for acromegaly, a condition caused by too much growth hormone. 45 healthy men will receive either MAR002 or a placebo to check for side effects and how the drug moves thr…
Phase: PHASE1 • Sponsor: Marea Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 07:12 UTC